Radioligand Therapy Readiness Assessment Framework applied in the Republic of Korea

27 September 2023

On 7 July 2023, a multidisciplinary group of experts discussed the question ‘what is needed to ready the Republic of Korea (ROK) for the future of radioligand therapy?’. The group had convened for a webinar hosted by GR Korea, a professional government relations and public affairs consultancy in the ROK, with support from The Health Policy Partnership.

The webinar presented research by GR Korea which used the structure of the Radioligand Therapy Readiness Assessment Framework, an international tool we launched back in June 2021. The framework explores readiness across five domains of the health system: governance, regulation and reimbursement, identified need, service provision, and health information.

This is the first time that an organisation has utilised our framework and published their results. We hope this shows that the framework can be applied in any country across the world, and we look forward to seeing more results from its use in the future.

You can download the Radioligand Therapy Readiness Assessment Framework and the reports from its application in the ROK here.